Get started
Author

Laura Hooijmaijers

Observed names: Hooijmaijers, L., Hooijmaijers, L.A.E., L. Hooijmaijers
ORCID: 0000-0002-2691-8931
Observed ORCID: 0000-0002-2691-8931
OpenAlex ID: A5104580264
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancer
2024 · Ralph J. A. Maas, Janneke S. Hoogstad-van Evert, et al. · Frontiers in Immunology · 23
PDF
IL-15 transpresentation by ovarian cancer cells improves CD34 + progenitor-derived NK cell's anti-tumor functionality
2025 · M. Vidal-Manrique, T. Nieuwenstein, et al. · OncoImmunology · 11
PDF
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity
2023 · Paulien M.M. van Hauten, Laura Hooijmaijers, et al. · Cytotherapy · 10
PDF
Good manufacturing practice production of an off-the-shelf CD34+ progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rgnull mice
2025 · Laura Hooijmaijers, Marcos Vidal-Manrique, et al. · Cellular and Molecular Life Sciences · 7
PDF
Differentiated mouse kidney tubuloids as a novel in vitro model to study collecting duct physiology
2023 · C. J. A. Olde Hanhof, E. Dilmen, et al. · Frontiers in Cell and Developmental Biology · 6
PDF
Correction: Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibition
2026 · Marcos Vidal-Manrique, Laura Hooijmaijers, et al. · Frontiers in Immunology
PDF
Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibition
2026 · Marcos Vidal-Manrique, Laura Hooijmaijers, et al. · Frontiers in Immunology
PDF
IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality
2026 · Hooijmaijers, L., de Jonge, P.K.J.D., et al.
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity
2026 · van Hauten, P.M.M., Hooijmaijers, L., et al. · Radboud Repository (Radboud University)
From Blueprint to Bedside: Constructing Off-the-shelf, Targeted NK cell Therapies for Cancer
2026 · Hooijmaijers, L.A.E. · Radboud Repository (Radboud University)
Works count: 10
Citation count: 57
H-index: 5
I10-index: 3
Year
Topic
Type